The SARS-CoV-2 (COVID-19) Antigen Rapid Test (Saliva) is a single-use test intended to detect in human saliva the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is designed for home use with saliva samples collected independently from symptomatic individuals suspected of being infected with SARS-CoV-2. With the rapid SARS-CoV-2 (COVID-19) antigen test (Saliva), only a preliminary result is obtained; final confirmation should be based on the results of clinical diagnosis. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions for use carefully.
SCREEN ITALIA
Italy
Rapid test for qualitative detection of protein nucleocapsid SARS-CoV-2 and nucleoprotein antigens of influenza A and influenza B present in the nasal swab sample. The Rapid COVID-19 and Influenza A + B Antigen Test (nasal swab) is a membrane-based qualitative immunoassay for the determination of SARS-CoV-2 and Influenza A + B antigens from a swab of human nasal sample. Result in 15 minutes. Screen Test Sars-Cov-2 + Influenza A + B is an in vitro diagnostic Medical Device CE 1434. Read the warnings and operating instructions carefully.
Request for a quoteSCREEN ITALIA
Italy
Influenza A+B Rapid Test – Product code: SC-0623-20 Rapid test for the qualitative detection of the Influenza A and Influenza B virus on samples of nasal swab, throat swab or nasal aspirate. The Influenza A + B rapid test is a rapid immunochromatographic test for the qualitative identification of influenza A and B antigens on nasal, pharyngeal or nasal aspirate swab samples. It is intended to assist in the rapid differential diagnosis of viral infections of influenza A and B. Influenza is an acute, highly contagious viral infection of the respiratory tract. It is a highly transmissible contagious disease through coughing and sneezing from suspended droplets containing the live virus. The peak of the flu usually occurs during the winter and autumn months each year. Type A viruses are usually more prevalent than type B and associated with more serious influenza outbreaks, while type B infections are usually milder.
Request for a quoteSCREEN ITALIA
Italy
The Clostridium difficile Toxin A + Toxin B combination rapid test (Feces) is a rapid chromatographic immunoassay for the qualitative detection of Toxin A and Toxin B Clostridium difficile antigens in human stool samples. The Clostridium difficile Toxin A + Toxin B Combination Rapid Test detects two distinct antigens in stool samples for C. difficile, viz., Toxin A and Toxin B on two different test strips in the same device, thus simultaneously detects two specific Clostridium antigens hard. Clostridium difficile is an anaerobic bacterium that acts as an opportunistic pathogen: it grows in the intestine when the normal flora is altered by antibiotic therapy. Toxigenic strains of Clostridium difficile cause infections from simple diarrhea to pseudomembranous colitis, which can even cause death. The disease is caused by two toxins produced by the toxigenic strains of C. difficile:
Request for a quoteSCREEN ITALIA
Italy
Rapid test for the qualitative detection of Helicobacter pylori (H.pylori) antigens in human feces. For professional in vitro diagnostic use only. The rapid test for H. pylori antigen (Feces) is a chromatographic immunoassay for the qualitative identification of H. pylori antigens. pylori in stools to aid in the diagnosis of H. pylori infection. The H. pylori is a small coiled bacterium that lives on the surface of the stomach and duodenum. It is involved in the etiology of various gastrointestinal disorders, including duodenal and gastric ulcers, non-ulcer dyspepsia and acute and chronic gastritis. Both invasive and non-invasive methods are used to diagnose H. pylori infection in patients with symptoms of gastrointestinal diseases. Sample and costly invasive diagnostic methods include gastric or duodenal biopsy followed by urease test (presumable), culture and / or histological section.
Request for a quote